4Thd Pharma Profile
Key Indicators
- Authorised Capital ₹ 21.35 Cr
as on 17-11-2024
- Paid Up Capital ₹ 21.30 Cr
as on 17-11-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -361.57%
(FY 2023)
- Ebitda -1765.52%
(FY 2023)
- Net Worth -18.32%
(FY 2023)
- Total Assets 42.63%
(FY 2023)
About 4Thd Pharma
The Corporate was formerly known as Fourth Dimension Integrated Marketing Communications Private Limited. The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 21.35 Cr and a paid-up capital of Rs 21.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Archana Bhatnagar, Anju Bala, and Subhash Sehgal serve as directors at the Company.
- CIN/LLPIN
U24100DL2008PTC176989
- Company No.
176989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at 4Thd Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Bhatnagar  | Director | 03-Oct-2016 | Current |
| Anju Bala | Director | 14-Nov-2024 | Current |
| Subhash Sehgal | Director | 22-Apr-2008 | Current |
Financial Performance and Corporate Structure Insights of 4Thd Pharma.
4Thd Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 361.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 4Thd Pharma?
In 2023, 4Thd Pharma had a promoter holding of 10.00% and a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ozone Pharmaceuticals LimitedActive 33 years 9 monthsAnju Bala and Subhash Sehgal are mutual person
Assam Agrotech Private LimitedActive 14 years 3 monthsArchana Bhatnagar and Subhash Sehgal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at 4Thd Pharma?
Unlock and access historical data on people associated with 4Thd Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 4Thd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 4Thd Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
